CGTX

0.58223.06%
JA

Jack A. Khattar

President, CEO & Director

Mr. Jack A. Khattar, M.B.A., is President, CEO & Director of Supernus, Inc. (Earlier known as Indivior Pharmaceuticals, Inc.) from November 2, 2026. He founded Supernus Pharmaceuticals, Inc. (Formerly, Shire Laboratories, Inc.) in 2005 and has served as Chief Executive Officer, President, Secretary and Director since 2005. He is President, Treasurer and Director of Sage Therapeutics, Inc. from July 31, 2025. He serves as President, Treasurer, Secretary & Director at Adamas Pharmaceuticals, Inc. since November 24, 2021. he is Member of Advisory Board of New Rhein Healthcare Investors LLC. From 1999 to 2005, Mr. Khattar served in various positions during that time as a Board member, President and Chief Executive Officer of Shire Laboratories Inc. the drug delivery subsidiary of Shire plc. Mr. Khattar serves as an Independent Chairman of the Board at Cognition Therapeutics, Inc. since April 2021. He has leadership, executive, Managerial, business and pharmaceutical company experience, along with industry experience in the development and commercialization of pharmaceutical products and drug delivery technologies. Mr. Khattar served as an Executive Officer at CIMA Labs Inc. (CIMA) where he was also responsible for business development, corporate alliances and strategic planning. He joined CIMA in 1995. Prior to CIMA, Mr. Khattar held several marketing and business development positions at Merck & Co. Novartis International AG, Playtex and Kodak Company in various locations, including the United States, Europe and the Middle East. Mr. Khattar served on the Board of Rockville Economic Development, Inc. from 2003 to 2013. He served on the Board of Directors of Prevacus, Inc. from 2015 to 2020. He serves as Independent Director at Cognition Therapeutics Inc. since July 2020. He serves as Director at Navitor Pharmaceuticals, Inc. since 2020. He has served on the Advisory Board of New Rhein Healthcare since 2019. Mr. Khattar has been Chairman of the Board of Directors of scPharmaceuticals Inc. since November 2017 and has been Director since June 2016. Mr. Khattar earned his degrees in Marketing with a BBA from American University of Beirut and an MBA from the Wharton School of the University of Pennsylvania.

Positions